- জেনেরিক নাম
- Rivaroxaban
- শক্তি
- 15 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Opsonin Pharma Limited
Xarelta 15 Tablet
Xarelta 15 Tablet সম্পর্কে
Xarelta 15 Tablet একটি ট্যাবলেট ঔষধ, যার জেনেরিক নাম Rivaroxaban এবং শক্তি ১৫ mg। Xarelta 15 প্রস্তুত করেছে Opsonin Pharma Limited। Xarelta 15-এর সাথে Rivaroxaban-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Rivaroxaban-এর ১৯টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Rivadel 2.5 Tablet-এর, প্রতি ইউনিট ৳ ৫।
Xarelta 15 Tablet কী?
Xarelta 15 15 mg is a tablet product of Opsonin Pharma Limited that contains Rivaroxaban. Anti-coagulants such as this are used in conditions where the risk of unwanted clots is a concern. Its active ingredient, Rivaroxaban, belongs to a group of medicines called oral anticoagulants. The doctor decides the dose and course.
Xarelta 15-এর ব্যবহার
Xarelta 15 is used as an anticoagulant. Which situation applies to you depends on your own condition. It is an oral anticoagulant and is not meant for self-treatment. Ask your doctor whether it is right for your condition.
Xarelta 15 কীভাবে ব্যবহার করবেন
Swallow the tablet whole with water; do not crush or chew it. Xarelta 15 is taken by mouth. Complete the course exactly as prescribed. If you miss a dose, ask your doctor or pharmacist what to do.
Xarelta 15-এর পার্শ্বপ্রতিক্রিয়া
There is also a risk of spinal or epidural haematoma, particularly with spinal procedures. The most common side effect of Rivaroxaban is a greater chance of bleeding, which may appear as bruising, nosebleeds or bleeding gums, or bleeding that is hard to stop. Tell your doctor promptly about any unusual or persistent bleeding, or any new symptoms. Ask your doctor or pharmacist about any other effects you notice while taking Xarelta 15.
সতর্কতা ও নিরাপত্তা
It must not be used by anyone with a known allergy to Rivaroxaban or the tablet's other ingredients, or with active pathological bleeding. Pregnant or breastfeeding women should speak to their doctor first. Do not stop the medicine suddenly without alternative anti-coagulation advice.
সাধারণ প্রশ্ন
Why is Xarelta 15 prescribed?
Xarelta 15 is used as an anticoagulant. Which situation applies to you depends on your own condition.
How should I take Xarelta 15?
Swallow the tablet whole with water; do not crush or chew it. Xarelta 15 is taken by mouth.
What should I watch for while using Xarelta 15?
There is also a risk of spinal or epidural haematoma, particularly with spinal procedures. The most common side effect of Rivaroxaban is a greater chance of bleeding, which may appear as bruising, nosebleeds or bleeding gums, or bleeding that is hard to stop.
Is Xarelta 15 safe for everyone?
It must not be used by anyone with a known allergy to Rivaroxaban or the tablet's other ingredients, or with active pathological bleeding. Pregnant or breastfeeding women should speak to their doctor first.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban 2.5 mg:- For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
- For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
- To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
- Deep vein thrombosis (DVT) & pulmonary embolism (PE) and reduction in the risk of recurrence of DVT and of PE
- For the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban 2.5 mg:- The recommended dose: 2.5 mg twice daily. Patients should also take a daily dose of 75-100 mg Aspirin or a daily dose of 75-100 mg Aspirin in addition to either a daily dose of 75 mg clopidogrel or a standard daily dose of ticlopidine.
- Nonvalvular Atrial Fibrillation: For patients with Creatinin Clearance >50 mL/min: 20 mg orally, once daily with the evening meal. For patients with Creatinin Clearance 15-50 ml/min: 15 mg orally, once daily with the evening meal.
- Treatment of DVT & PE: 15 mg orally twice daily with food for the first 21 days for the initial treatment of acute DVT or PE. After the initial treatment period, 20 mg orally once daily with food for the remaining treatment.
- Prevention in the risk of recurrence of DVT and of PE: 20 mg once daily with food.
- Prophylaxis of DVT following Hip replacement surgery: 10 mg once daily for 35 days.
- Prophylaxis of DVT following knee replacement surgery: 10 mg once daily for 12 days.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Concomitant use with drugs that are combined P-gp and CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, erythromycin, fluconazole, diltiazem, verapamil, dronedarone) increases in Rivaroxaban exposure and pharmacodynamic effects (i.e., factor Xa inhibition and PT prolongation), that’s why should be avoided. Co-administration of Rivaroxaban with a combined P-gp and strong CYP3A4 inducer (e.g., rifampicin, phenytoin, carbamazepine) decreases the efficacy of Rivaroxaban and also should be avoided. The concomitant use of other drugs like anti-platelet agents, heparin, fibrinolytic therapy, NSAIDs may cause an increased risk of bleeding.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
It is contraindicated in patients with known hypersensitivity of Rivaroxaban or any of the excipients of the product. It is also contraindicated in patients with active pathological bleeding.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The most common side effects of Rivaroxaban have increased chance of bleeding, spinal or epidural hematoma and increased risk of stroke after discontinuation in nonvalvular atrial fibrillation.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban is a pregnancy category C drug. There are no adequate or well-controlled studies of Rivaroxaban in pregnant women, and dosing for pregnant women has not been established. It is not known if Rivaroxaban is excreted in human milk. The safety and efficacy of Rivaroxaban has not been established in breastfeeding women.সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Early discontinuation of Rivaroxaban, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. Rivaroxaban increases the risk of bleeding that can be fatal in presence of following risk factors- bleeding disorders, uncontrolled severe arterial hypertension, gastrointestinal disease (e.g., inflammatory bowel disease, oesophagitis, gastritis and gastroesophageal reflux disease), vascular retinopathy, bronchiectasis, history of pulmonary bleeding. Signs or symptoms of neurological impairment should be monitored in case of neuraxial anesthesia (spinal/epidural anesthesia) or spinal puncture as epidural or spinal hematoma can occur. Rivaroxaban is not recommended in patients with pulmonary embolism who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy.মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Overdose of Rivaroxaban may lead to hemorrhage. Rivaroxaban systemic exposure is not further increased at single doses >50 mg due to limited absorption. A specific antidote for Rivaroxaban is not available. The use of activated charcoal to reduce absorption in case of Rivaroxaban overdose may be considered. Partial reversal of laboratory anticoagulation parameters may be achieved with use of plasma products.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store in a cool (below 30°C) & dry place protected from light. Keep away from the reach of children.বিকল্প ব্র্যান্ড: Rivaroxaban
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।